We are looking for bright, motivated people who are passionate about changing the lives of cancer patients using their basic science, clinical and management skills!
The Ghobrial Lab in Boston, headed by Dr. Irene Ghobrial, MD, Professor of Medicine, (https://connects.catalyst.harvard.edu/Profiles/display/Person/75208), is affiliated with Harvard Medical School, Dana-Farber Cancer Institute, and the Broad Institute, and is seeking to hire 1 full-time translational lab manager (BS or MS level) to be in charge of acquisition, storage, clinical annotation and sequencing operations involving patient samples.
The Ghobrial lab (https://ghobriallab.dana-farber.org/) comprises clinicians and scientists who work on bulk and single-cell sequencing of tumors and their microenvironment (DNA, RNA, protein, epigenetics), as well as liquid biopsy, functional genomics, drug development and computational biology in patients with Multiple Myeloma and its precursor conditions, Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma. Our science is conducted in close collaboration with Irene’s clinical team, that is in charge of caring for patients and conducting multiple clinical trials. Irene and a team of collaborators have recently received the prestigious Stand Up 2 Cancer Dream Team award (https://standuptocancer.org/research/research-portfolio/dream-teams/precursor-myeloma-dream-team/), which will allow us to screen 50,000 individuals at high risk for developing multiple myeloma, in the largest US population study on myeloma precursors to date.
You will be working with clinicians, project managers, basic and translational scientists (wet and dry lab), working together to improve our understanding of myeloma biology, discover new therapeutic targets, and identify ways to prevent progression from MGUS/SMM to overt myeloma. Your responsibilities will include attending clinical meetings, managing the acquisition and storage of patient samples with the help of research technicians, organizing the biobank and annotating patient samples with clinical information and bioinformatics results, as well as preparing and standardizing DNA/RNA libraries for sequencing (automated pipeline).
Ideal candidates will have a Bachelors or Masters in a relevant discipline, wet lab experience and an interest in working closer with clinicians to improve outcomes for patients with Multiple Myeloma and its precursor conditions. They should have excellent communication and initiative, be approachable and always willing to help, and be excited by growing and learning across a broad range of disciplines.
Located in Boston and the surrounding communities, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.
Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.